Lymphotoxin-? receptor-NIK signaling induces alternative RELB/NF-?B2 activation to promote metastatic gene expression and cell migration in head and neck cancer.

ABSTRACT: Head and neck squamous cell carcinomas (HNSCC) preferentially spread to regional cervical tissues and lymph nodes. Here, we hypothesized that lymphotoxin-? (LT?), receptor LT?R, and NF-?B-inducing kinase (NIK), promote the aberrant activation of alternative NF-?B2/RELB pathway and genes, that enhance migration and invasion of HNSCC. Genomic and expression alterations of the alternative NF-kB pathway were examined in 279 HNSCC tumors from The Cancer Genome Atlas (TCGA) and a panel of HNSCC lines. LT?R is amplified or overexpressed in HNSCC of the larynx or oral cavity, while LT?, NIK, and RELB are overexpressed in cancers arising within lymphoid oropharyngeal and tonsillar sites. Similarly, subsets of HNSCC lines displayed overexpression of LT?R, NIK, and RELB proteins. Recombinant LT?, and siRNA depletion of endogenous LT?R and NIK, modulated expression of LT?R, NIK, and nuclear translocation of NF-?B2(p52)/RELB as well as functional NF-?B promoter reporter activity. Treatment with a NIK inhibitor (1,3[2H,4H]-Iso-Quinoline Dione) reduced the protein expression of NIK and NF-?B2(p52)/RELB, and blocked LT? induced nuclear translocation of RELB. NIK and RELB siRNA knockdown or NIK inhibitor slowed HNSCC migration or invation in vitro. LT?-induces expression of migration and metastasis related genes, including hepatocyte growth/scatter factor receptor MET. Knockdown of NIK or MET similarly inhibited the migration of HNSCC cell lines. This may help explain why HNSCC preferentially migrate to local lymph nodes, where LT? is expressed. Our findings show that LT?/LT?R promotes activation of the alternative NIK-NF-?B2/RELB pathway to enhance MET-mediated cell migration in HNSCC, which could be potential therapeutic targets in HNSCC.

SUBMITTER: Das R 

PROVIDER: S-EPMC7066987 | biostudies-literature | 2019 Mar

REPOSITORIES: biostudies-literature